This antiviral drug can speed up recovery of Covid-19 patients

This antiviral drug can speed up recovery of Covid-19 patients

An international team of researchers has found that an antiviral drug - interferon(IFN)-a2b - can help speed up the recovery of Covid-19 patients.. Published in the journal Frontiers in Immunology, the study revealed that treatment with interferon(IFN)-a2b may significantly accelerate virus clearance and reduce levels of inflammatory proteins in Covid-19 patients.". Rather than developing a virus-specific antiviral for each new virus outbreak, we should consider interferons as the 'first responders' in terms of treatment," said study lead researcher Dr Eleanor Fish professor in the University of Toronto, Canada.. The research team considered IFN-a therapy for Covid-19 after they demonstrated interferon provided therapeutic benefit during the SARS outbreak of 2002 and 2003.They found that treatment with this drug, which has been used clinically for many years, significantly reduced the duration of detectable virus in the upper respiratory tract, on average by about seven days.. It also reduced blood levels of interleukin(IL)-6 and C-reactive protein (CRP), two inflammatory proteins found in Covid-19 patients.. For the findings, the researchers conducted this exploratory study on a group of 77 patients with Covid-19 in Wuhan, China.. According to the researchers, he work provides several important and novel insights into Covid-19 disease, notably that treatment with